328
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Canadian poison control centres: preliminary assessment of their potential as a resource for public health surveillance

, , &
Pages 886-891 | Received 11 Jul 2013, Accepted 30 Aug 2013, Published online: 18 Oct 2013

References

  • Public Health Agency of Canada, Injury Surveillance On-Line. Leading causes of injury deaths in Canada, 2005. Ottawa,ON: PHAC; 2005. Available from: http://dsol-smed.hc-sc.gc.ca/dsol-smed/is-sb/leadcauses/leading_causes_inj_mort_2005-eng.pdf. Accessed December 8, 2011.
  • SMARTRISK. The economic burden of injury in Canada. Toronto, ON: SMARTRISK; 2009.
  • Naylor D, Basrur S, Bergeron MG, Brunham RC, Butler-Jones D, Dafoe G, et al. Learning from SARS: Renewal of public health in Canada. Ottawa, ON. 2003. Available from: http://www.phac-aspc.gc.ca/publicat/sars-sras/pdf/sars-e.pdf. Accessed August 10, 2012.
  • Wolkin AF, Martin CA, Law RK, Schier JG, Bronstein AC. Using poison center data for national public health surveillance for chemical and poison exposure and associated illness. Ann Emerg Med 2012; 59:56–61.
  • Artalejo L, Crouch B, Geller RJ, Marcus S, Schauben J, (Working Group of Poison Control Representatives). The value of the poison control center. Washington, DC: U.S. Department of Health and Human Services, Health Resources and Services Administration Poison Control Program; 2008. Available from: http://www.aapcc.org/dnn/LinkClick.aspx?fileticket = YbyVEIEON3Q%3D&tabid = 383&mid = 1002. Accessed October 24, 2011.
  • Hughes AA, Bogdan GM, Dart RC. Active surveillance of abused and misused prescription opioids using poison center data: A pilot study and descriptive comparison. Clin Toxicol 2007; 45:144–151.
  • Derby MP, McNally J, Ranger-Moore J, Hulette L, Villar R, Hysong T, et al. Poison control center-based syndromic surveillance for foodborne illness. MMWR Morb Mortal Wkly Rep 2005; 54:35–40.
  • Medus C, Meyer S, Smith K, Jawahir S, Miller B, Viger K, et al. Multistate outbreak of salmonella infections associated with peanut butter and peanut butter—containing products—United States, 2008-2009. J Am Med Assoc 2009; 301:1119–1122.
  • Flesch F, Rigaux-Barry F, Saviuc P, Garnier R, Daoudi J, Blanc I, et al. Dysgeusia following consumption of pine nuts: More than 3000 cases in France. Clin Toxicol 2011; 49:668–670.
  • Wu AHB, Smith A, McComb R, Bowers GN Jr, Makowski GS, McKay CA Jr, et al. State-wide hospital clinical laboratory plan for measuring cholinesterase activity for individuals suspected of exposure to nerve agent chemical weapons. Clin Toxicol 2008; 46:110–116.
  • Wolkin AF, Patel M, Watson W, Belson M, Rubin C, Schier J, et al. Early detection of illness associated with poisonings of public health significance. Ann Emerg Med 2006; 47:170–176.
  • Cobaugh DJ, Krenzelok EP. Adverse drug reactions and therapeutic errors in older adults: a hazard factor analysis of poison center data. Am J Health Syst Pharm 2006; 63:2228–2234.
  • Volans GN, Karalliedde L, Wiseman HM. Poisons centres and the reporting of adverse drug events: the case for further development. Drug Safety 2007; 30:191–194.
  • Simone KE, Spiller HA. Poison center surveillance data: the good, the bad and.. the flu.Clin Toxicol 2010; 48:415–417.
  • Graber JM, Smith AE. Results from a state-based surveillance system for carbon monoxide poisoning. Public Health Rep 2007; 122:145–154.
  • Abelsohn A, Frank J, Eyles J. Environmental public health tracking/ surveillance in Canada: a commentary. Healthcare Policy 2009; 4: 37–52.
  • Durigon M, Kosatsky T. Calls managed by the BC drug and poison information centre following the 2011 nuclear reactor incident at Fukushima, Japan. Can Pharm J 2012; 145:256–258.e1.
  • Ferguson JA, Sellar C, McGuigan MA. Predictors of pesticide poisoning. Can J Public Health 1991; 82:157–161.
  • Fitchette B. The ethics of referral and intervention with non-life threatening suicide attempts by overdose of medication and ingestion of harmful substances. Omega J Death Dying 1996;33:179.
  • Lévy A, Bailey B, Letarte A, Dupuis C, Lefebvre M. Unproven ingestion: an unrecognized bias in toxicological case series. Clin Toxicol 2007; 45:946–949.
  • Ackroyd-Stolarz SA, MacKinnon NJ, Murphy N, Gillespie E, Zed PJ. Adverse events related to medications identified by a Canadian poison centre. J Popul Ther Clin Pharmacol 2011; 18:e250–e256.
  • American Association of Poison Control Centres. 2012 CSPI exam candidate handbook Alexandria, Virginia: AAPCC; 2012.
  • Waring WS, Palmer SR, Bateman DN. Alerting and surveillance using poisons information systems (ASPIS): Outcomes from an international working group. Clin Toxicol 2007; 45:543–548.
  • Kay R, Hopkins R, Blackmore C, Johnson D, Schauben J, Weisman R, et al. Monitoring poison control center data to detect health hazards during hurricane season—Florida, 2003-2005. MMWR Morb Mortal Wkly Rep 2006; 55:426–428.
  • Hampson N, Dunn S, Bronstein A, Fife C, Villanacci J, Zane D, et al. Carbon monoxide exposures after hurricane Ike - Texas, September 2008. MMWR Morb Mortal Wkly Rep 2009; 58:845–849.
  • Friedman LS. Real-time surveillance of illicit drug overdoses using poison center data. Clin Toxicol 2009; 47:573–579.
  • Mrvos R, Krenzelok EP. Surveillance of drug identification calls: an overlooked poison center responsibility. Vet Hum Toxicol 2002; 44:294–295.
  • Lefranc A, Flesch F, Cochet A, Daoudi J, Crinier R. Epidemiological description of an outbreak of dermatitis related to dimethylfumarate, France, 2008. Arch Environ Occup Health 2011; 66:217–222.
  • Gryzlak BM, Wallace RB, Zimmerman MB, Nisly NL. National surveillance of herbal dietary supplement exposures: The poison control center experience. Pharmacoepidemiol Drug Saf 2007; 16:947–957.
  • Haller CA, Kearney T, Bent S, Ko R, Benowitz NL, Olson K. Dietary supplement adverse events: report of a one-year poison center surveillance project. J Med Toxicol 2008; 4:84–92.
  • Davanzo F, Settimi L, Condo M, Marcello I, Zoppi F, Binetti R. A cluster of methanol-related poisonings in Sicily: case characterization and identification of unexpected sources of exposure. [Italian]. Epidemiol Prev 2009; 33:104–112.
  • Lazor-Blanchet C, Rusca S, Vernez D, Berry R, Albrecht E, Droz PO, Boillat MA. Acute pulmonary toxicity following occupational exposure to a floor stain protector in the building industry in Switzerland. Int Arch Occup Environ Health 2004; 77:244–248.
  • Marsolek MR, White NC, Litovitz TL. Inhalant abuse: monitoring trends by using poison control data, 1993-2008. Pediatrics 2010; 125:906–913.
  • Bentur Y, Lurie Y, Cahana A, Lavon O, Bloom-Krasik A, Kovler N, et al. Poisoning in Israel: Annual report of the Israel poison information center, 2007. Isr Med Assoc J 2008; 10:749–756.
  • Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL. 2009 Annual report of the american association of poison control centers’ national poison data system (NPDS): 27th annual report. Clin Toxicol 2010; 48:979–1178.
  • Committee on Poison Prevention and Control, Board on Health Promotion and Disease Prevention. Forging a poison prevention and control system. Washington, DC: The National Academies Press; 2004.
  • British Columbia Centre for Disease Control. Mandate and partners. Vancouver, BC: Provincial Health Services Authority; 2011 [cited 2012 June 19]; Available from: http://www.bccdc.ca/util/about/mission/default.htm. Accessed June 19, 2012.
  • Verrier A, Daoudi J, Gourier-Frry C, Salines G. Carbon monoxide poisoning surveillance: a french environmental & health surveillance system integrated in preventive policies. Inj Prev 2010; 16:A263–A264.
  • Verrier A. French carbon monoxide poisoning surveillance system. ESCAIDE; Stockholm Sweden 2009. Available from: http://escaide2009.ecdc.europa.eu/download.cfm-SAVE = 2486 & LG = 1.pdf. Accessed October 24, 2011.
  • Hamilton J. Quebec's ice storm ’98: ‘All cards wild, all rules broken’ in Quebec's shell-shocked hospitals. CMAJ 1998; 158:520.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.